Tumor Targeting: Utilizing Spatial Data Science Techniques To Decode the Enigmatic Immune Response With the Goal of Informing Further Efforts to Develop Immunotherapies for Tumor Treatment
ISEF · 2022 Computational Biology and Bioinformatics Fourth Award
Overview
Cancer is one of the deadliest illnesses in the world, and to find a cure for cancer, information must be obtained on the human body’s response to tumors. The purpose of this study was to identify the methods that the immune system uses to respond to tumors and to identify spatial patterns in the tumor microenvironment. This was accomplished by using multiplexed-immunofluorescence (MIF) images of the tumor microenvironment provided by Mayo Clinic. The study analyzed the composition of cells at different distances away from the margin between the tumor and stroma regions classified as “intact,” where the immune system has no discernable advantage over the tumor. Annotations of the regions were drawn to identify the margin, and the relevant cells were determined using geospatial analysis techniques. It was found that specific types of cells tend to more frequently increase, or decrease, as distance from the margin increases. The study also conducted analysis on different types of regions with tumor pathology. The types examined were part of two groups: “Responder” (patient responded to immunotherapies) and “non-responder” (patient did not respond). The composition of cells in these regions was examined, along with the participation index (a measure of colocation). It was found that certain cell types are more prevalent in responder regions, and tumor cells are more prevalent in non-responder regions. Additionally, certain cells exhibit higher rates of colocation with tumor cells in responder samples. This work fosters better understanding of the immune response to tumors and informs efforts to develop immunotherapies.
Awards (2)
- Fourth Award of $500 $500
- Fourth Award of $500 $500
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2025
Spatial Tumor-Immune Analysis: Insights From Pathology Slides and Breast Cancer Survival
ISEF · 2026
TMEInsight: Elucidating Patient-Specific Immune-Pathway Crosstalk via Deep Learning to Foreshadow Tumor Progression
ISEF · 2026
Development of Non-Invasive Imaging Biomarkers for Predicting Immunotherapy Response in Breast Cancer Patients
ISEF · 2017
A Novel Pan-Cancer Approach to Quantify Tumor Mutational Burden and Clinical Data Predictors for Immunotherapy Response towards Personalized Medicine
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair